CMPI.org

In the News

FDA is smashing the status quo for regulatory science

10/14/2019 12:00 AM | STAT

Common Sense Healthcare Policy for Common Sense Americans (and Presidential Candidates)

08/22/2019 12:00 AM | CMPI

Three ways Congress can lower seniors’ pharmacy bills

08/08/2019 12:00 AM | The Express Times

07/02/2019 12:00 AM | Real Clear Health

HHS's ideas for rearranging Medicare would raise costs for seniors

06/18/2019 12:00 AM | The Hill

FDA Hears Concerns About The Unregulated CBD Market

06/04/2019 12:00 AM | Forbes

Restoring the Balance Between Innovation and Generic Manufacturing of Medicines

04/26/2019 12:00 AM | CMPI

How ‘Right to Try’ Laws Fail Patients Who Need Experimental Medicine

04/24/2019 12:00 AM | Observer

Doggett-Brown Bill Destroys Drug Innovation

04/23/2019 12:00 AM | Inside Sources

A front for government price controls

04/22/2019 12:00 AM | The Washington Times

Peter Pitts discusses New York lawsuit against Opioid manufacturer on i24NEWS

04/01/2019 12:00 AM | i24NEWS

Health Care Chutzpah vs. Health Plan Literacy

03/14/2019 12:00 AM |

Peter Pitts moderates CPAC Panel - Promises Made, Promises Unkept: Time to get Serious About Healthcare

03/04/2019 12:00 AM |

America's health at stake

02/26/2019 12:00 AM | The Washington Times

Understanding the FDA's Take on Cannabidiol

02/19/2019 12:00 AM | Cancer Therapy Advisor

It’s time to get serious about the economics of expanded access

01/30/2019 12:00 AM | STAT

Health sharing, a viable option for health care

01/08/2019 12:00 AM | The Washington Times

Elizabeth Warren's Threat to Medical Progress

01/06/2019 12:00 AM | RealClearHealth

HHS Drug Price Plan Is a Gift to Global ‘Freeloaders’

12/27/2018 12:00 AM | RealClearHealth

Zeroing Out Drug Prices

12/17/2018 12:00 AM | Morning Consult

Previous
1
...
3
4
5
6
7
8
9
...
11
Next

RECENT NEWS

The coronavirus could help pharma reset its reputation in Washington

STAT
03/03/2020 12:00 AM

The coronavirus could help pharma reset its reputation in Washington

The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington.... Read more

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

STAT
10/17/2024 12:00 AM

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Differing philosophies within and outside of government could doom the hub... Read more

Tort bar’s newest collateral damage: Preterm babies

The Washington Times
07/02/2024 12:00 AM

Tort bar’s newest collateral damage: Preterm babies

Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers... Read more

Read all News